Second Systemic Sclerosis World Congress a Success PDF Print E-mail
Tuesday, 13 March 2012 14:09
Great success for the second Systemic Sclerosis World Congress that was held in February at the Palacio de Congresos de Madrid.

After the positive experience of 2010 in Florence, AIM Group International organised the second edition the congress, on behalf of World Scleroderma Foundation, founded by Alexander Klee, grandson of the great painter Paul Klee, who also a suffers from scleroderma, a so-called "rare" disease with very painful and debilitating effects.

To approach the social aspects of the disease, the Congress opened to the patients’ associations (FESCA - Scleroderma Federation of European Associations) and organized a parallel conference with hundreds of patients who had the opportunity to debate on clinical cases, experiences and opinions with experts and prominent international physicians.

With a qualified program consisting of seventy seven lectures, around sixty oral presentations and three hundred posters, the Congress attracted over 1,300 delegates from around the world: in fact, in addition to a prevalent presence from European countries, some hundred American, Asian and African participants contributed to reinforcing the international nature of the meeting.

At the end of the World Congress, the Scleroderma Foundation, chaired by Prof. Marco Matucci Cerinic, AIM Group International were appointed for the organisation of the next Congress, to be held in Paris in 2014.

Source: Agency & Association (2012), "The World Scleroderma Foundation meets in Madrid for the “Systemic Sclerosis World Congress” organised by AIM Group International"; ITCM

 
More articles :

» Study Suggests Link Between Scleroderma, Cancer in Certain Patients

Patients with a certain type of may get cancer and scleroderma simultaneously, Johns Hopkins researchers have found, suggesting that in some diseases, autoimmunity and cancer may be linked.These findings could lead researchers closer to discovering...

» Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Tracy Frech, Kirsten Novak, Monica P. Revelo, Maureen Murtaugh, Boaz Markewitz, Nathan Hatton, Mary Beth Scholand, Edward Frech, David Markewitz, and Allen D. SawitzkeReceived 31 May 2011; Accepted 14 July 2011Systemic sclerosis (SSc; scleroderma)...

» Greater Global Cooperation and Collaboration in Scleroderma Research Required

Greater global cooperation and collaboration among Scleroderma researchers and clinicians would be all that is required to fuel a drive toward important discoveries and optimize outcomes for patients with this chronic, progressive, and often...

» Women At Higher Risk For Autoimmune Diseases

In a recent article on , it was reiterated that women are at a significantly higher risk of contracting an autoimmune disease than men, according to an expert in the field. Dr Vivian Pinn, director of the National Institutes of Health recently...

» Rare Disease Research Teams Receive Over $17m In Funding

(CIHR) has formed 9 new research teams that will focus on rare diseases. Funding from the CIHR will total $15.4 million over five years, primarily through the Institute of Genetics and the Institute of Nutrition, Metabolism, and Diabetes, while...

» Patients With Scleroderma May Not Exhibit Increased Corneal Thickness

in patients with systemic sclerosis may not differ significantly from those of healthy patients, contrary to prior hypothesis, a study found."Because [] is characterized by increased deposition of and other connective tissue components in the skin...

Add comment

Do feel free to leave your comments, as they would add value and knowledge to the community. However, please refrain from making any disparaging, uninformed, or unrelated comments. Thanks :)

Security code
Refresh